Table 1.
Isolate | Inoculum (cfu/mL) | Time (h) | Log Change[=log10(CFUt)–log10(CFU0)] | ||||||
---|---|---|---|---|---|---|---|---|---|
LNE2 mg/L | FOS0.5 mg/L | FOS1 mg/L | FOS2 mg/L | FOS0.5 mg/L+LNE 2 mg/L | FOS1 mg/L + LNE 2 mg/L | FOS2 mg/L+ LNE2 mg/L | |||
29213 | ~105 | 24 | 1.98 | 2.83 | 2.38 | 0.47 | −1.18 | −1.91 | −2.40 |
L8 | ~105 | 24 | 3.71 | 2.70 | 1.67 | 1.09 | −1.32 | −2.79 | −4.81 |
L16 | ~105 | 24 | 3.66 | 2.82 | 1.67 | 0.42 | 0.79 | −1.23 | −1.82 |
L32 | ~105 | 24 | 4.23 | 2.72 | 2.14 | 0.11 | 0.83 | −0.91 | −1.75 |
Notes: Underlining indicates synergy (≥2 log10 decrease in the CFU/mL with the combination compared with its most active monotherapy) and bold formatting indicates additivity (1 to<2 log10 decrease in the CFU/mL with the combination compared with its most active monotherapy).
Abbreviations: LNE, linezolid; FOS, fosfomycin; CFU, colony-forming units.